CD8A and skin squamous cell carcinoma: As this suggests an immunosuppressive/inhibitory phenotype for CD8+CD103+ TRMs, we investigated their role in relation to clinical outcome in cSCC, and found that higher CD103 expression and higher CD103+ frequencies as a percentage of the CD8+ cell population were associated with the development of, and reduced time to, metastasis.